Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.
Christoph Höner Zu SiederdissenBernhard SchlevogtPhilipp SolbachKerstin PortMarkus CornbergMichael P MannsHeiner WedemeyerKatja DeterdingPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
During treatment, RBV leads to a reduced QOL, whereas RBV-free treatment leads to an increased QOL. After treatment, QOL strongly increases in both, RBV and RBV-free treated patients. Some patients perceive a sustained reduction in QOL, which seems unrelated to treatment.